Skip to main content
Clinical Trials/IRCT201311295605N6
IRCT201311295605N6
Completed
Phase 3

Clinical trial study in the comparison of topical betametazon versus topical tacrolimus 0.1% in the treatment of vitiligo

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Vitiligo.
Sponsor
Tabriz university of medical sciences
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with vitiligo over 2 years old and less than 30% of body surface area involved.
  • Exclusion criteria: Patients with allergy or hypersensitivity to macrolides; Pregnant and lactating women; Patients with immune deficiency and patients who had received vitiligo medications less than 6 months ago

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials